Literature DB >> 26038951

Cdk1 plays matchmaker for the Polo-like kinase and its activator SPAT-1/Bora.

Nicolas Tavernier1, Costanza Panbianco, Monica Gotta, Lionel Pintard.   

Abstract

Mitosis is orchestrated by several protein kinases including Cdks, Plks and Aurora kinases. Despite considerable progress toward understanding the individual function of these protein kinases, how their activity is coordinated in space and time during mitosis is less well understood. In a recent article published in the Journal of Cell Biology, we show that CDK-1 regulates PLK-1 activity during mitosis in C. elegans embryos through multisite phosphorylation of the PLK-1 activator SPAT-1 (Aurora Borealis, Bora in human). SPAT-1 variants mutated on CDK-1 phosphorylation sites results in severe delays in mitotic entry, mimicking embryos lacking spat-1 or plk-1 function. We further show that SPAT-1 phosphorylation by CDK-1 promotes its binding to PLK-1 and stimulates PLK-1 phosphorylation on its activator T-loop by Aurora A kinase in vitro. Likewise, we find that phosphorylation of Bora by Cdk1 promotes phosphorylation of human Plk1 by Aurora A suggesting that this mechanism is conserved in humans. These results indicate that Cdk1 regulates Plk1 by boosting its kinase activity. Here we discuss these recent findings and open questions regarding the regulation of Plk1/PLK-1 by Cdk1/CDK-1 and Bora/SPAT-1.

Entities:  

Keywords:  C. elegans; Cell cycle; Embryo; Mitosis

Mesh:

Substances:

Year:  2015        PMID: 26038951      PMCID: PMC4614671          DOI: 10.1080/15384101.2015.1053673

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  42 in total

1.  Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication.

Authors:  P Nash; X Tang; S Orlicky; Q Chen; F B Gertler; M D Mendenhall; F Sicheri; T Pawson; M Tyers
Journal:  Nature       Date:  2001-11-29       Impact factor: 49.962

2.  Mitotic effects of a constitutively active mutant of the Xenopus polo-like kinase Plx1.

Authors:  Y W Qian; E Erikson; J L Maller
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

3.  Functional studies on the role of the C-terminal domain of mammalian polo-like kinase.

Authors:  Young-Joo Jang; Chin-Yo Lin; Sheng Ma; Raymond L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

4.  Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates.

Authors:  Andrew E H Elia; Lewis C Cantley; Michael B Yaffe
Journal:  Science       Date:  2003-02-21       Impact factor: 47.728

5.  Plk1 promotes nuclear translocation of human Cdc25C during prophase.

Authors:  Fumiko Toyoshima-Morimoto; Eri Taniguchi; Eisuke Nishida
Journal:  EMBO Rep       Date:  2002-03-15       Impact factor: 8.807

Review 6.  Polo-like kinases and oncogenesis.

Authors:  Frank Eckerdt; Juping Yuan; Klaus Strebhardt
Journal:  Oncogene       Date:  2005-01-10       Impact factor: 9.867

7.  The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex.

Authors:  Kin-Yip Cheng; Edward D Lowe; John Sinclair; Erich A Nigg; Louise N Johnson
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

8.  M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.

Authors:  Nobumoto Watanabe; Harumi Arai; Yoshifumi Nishihara; Makoto Taniguchi; Naoko Watanabe; Tony Hunter; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

9.  Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk.

Authors:  K S Lee; T Z Grenfell; F R Yarm; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.

Authors:  Andrew E H Elia; Peter Rellos; Lesley F Haire; Jerry W Chao; Frank J Ivins; Katja Hoepker; Duaa Mohammad; Lewis C Cantley; Stephen J Smerdon; Michael B Yaffe
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

View more
  6 in total

1.  Modulation of KRAS Mutant by Inhibiting PLK1 Kinase in Cancer Therapeutics.

Authors:  Robert B Kargbo
Journal:  ACS Med Chem Lett       Date:  2021-09-15       Impact factor: 4.632

2.  Effects of Sepantronium Bromide (YM-155) on the Whole Transcriptome of MDA-MB-231 Cells: Highlight on Impaired ATR/ATM Fanconi Anemia DNA Damage Response.

Authors:  Elizabeth A Mazzio; Charles A Lewis; Rashid Elhag; Karam F Soliman
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 3.395

Review 3.  Regulatory functional territory of PLK-1 and their substrates beyond mitosis.

Authors:  Shiv Kumar; Garima Sharma; Chiranjib Chakraborty; Ashish Ranjan Sharma; Jaebong Kim
Journal:  Oncotarget       Date:  2017-06-06

Review 4.  A unified view of spatio-temporal control of mitotic entry: Polo kinase as the key.

Authors:  Lionel Pintard; Vincent Archambault
Journal:  Open Biol       Date:  2018-08       Impact factor: 6.411

5.  A polo-like kinase modulates cytokinesis and flagella biogenesis in Giardia lamblia.

Authors:  Eun-Ah Park; Juri Kim; Mee Young Shin; Soon-Jung Park
Journal:  Parasit Vectors       Date:  2021-03-31       Impact factor: 3.876

6.  Bora phosphorylation substitutes in trans for T-loop phosphorylation in Aurora A to promote mitotic entry.

Authors:  F Sicheri; L Pintard; N Tavernier; Y Thomas; S Vigneron; P Maisonneuve; S Orlicky; P Mader; S G Regmi; L Van Hove; N M Levinson; G Gasmi-Seabrook; N Joly; M Poteau; G Velez-Aguilera; O Gavet; A Castro; M Dasso; T Lorca
Journal:  Nat Commun       Date:  2021-03-26       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.